Peer Exchange Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.
All Peer Exchange Quantifying the Potential Impact of SGLT-2 Inhibitors in Heart Failure Considering Cost Effectiveness in Cardiovascular Risk Reduction Managed Care Consideration for an Emerging Class of Therapy in Anemia of Chronic Kidney Disease Value-based Considerations of CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer Patient Management of Chronic Fibrosing Interstitial Lung Disease With Progressive Phenotype Expanding Treatment Options for Metastatic Breast Cancer COPD Treatment Updates: Impact on Daily Life A Deeper Understanding of Wound Care Understanding the Comorbidities: Psoriasis and Metabolic Syndrome Managing Challenges of Insomnia in Elderly Patients The Challenges and Treatment of Sickle Cell Disease Identifying Secondary Progressive Multiple Sclerosis A Review of the Treatment for Multiple Myeloma Rare Neurological Diseases: Spinal Muscular Atrophy and Huntington's Disease An Introduction of a New Class for the Treatment of Bone Health An Overview of the Value-Based Marketplace The Progression of Type 2 Diabetes and the Treatment Options to Manage It Immunotherapy in the Oncology Care Model Preventive Treatments for Migraines The Use of Biologics for the Treatment of Asthma Improved Outcomes in the Management of Hepatic Encephalopathy Expert Perspectives on Schizophrenia Treatment Approaches and Relapse Prevention Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Oncology Stakeholders Summit, Summer 2018 Emerging Treatment for Migraine Advances in the Treatment of Hyperhidrosis Special Considerations in HIV Management Finding Value in Today's New Insulin Technology in Diabetes Care: From Prevention to Disease Management
Age-Related Macular Degeneration Treatments: Determining Appropriate Use Diabetes Therapy and Cardiovascular Outcomes: An Update Oncology Stakeholders Summit, Spring 2017 Reducing CVD Risk Through Optimal Lipid Management Oncology Stakeholders Summit, Fall 2016 Management Optimization in Atopic Dermatitis Oral Oncolytics: Exploring Challenges in Cost, Adherence, and Management Reducing Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus Oncology Stakeholders Summit, Spring 2016 Diabetes-Related Complications: A Focus on Diabetic Macular Edema Oncology Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit 2014 Diabetes and Obesity Management Prostate Cancer Rare Disease Neurological Disorders Immunotherapy Diabetes and Cardiometabolic Health
July 01, 2020 –
The panel provides key takeaways for the treatment of metastatic breast cancers.
June 29, 2020 –
The panel details which health care professionals are involved in diagnosing and managing chronic fibrosing interstitial lung disease with progressive phenotype.
June 29, 2020 –
Shared insight on the diagnosis of chronic fibrosing interstitial lung disease with progressive phenotype.
June 26, 2020 –
Kelli Davis, METAvivor patient advocate and co-founder of the Northwest Arkansas Metsquerade, and Steven Peskin, MD, MBA, FACP, executive medical director at Horizon Blue Cross Blue Shield of New Jersey, provide their perspectives as a patient and patient advocate and payer of value-based care.
June 24, 2020 –
Assessing the value of personalized medicine from a payer and provider perspective and the importance of evidence-based data.
June 24, 2020 –
Exploring the use of NGS testing in metastatic TNBC and a payer perspective on use of the appropriate companion diagnostic.
June 22, 2020 –
Multifaceted discussion on the presentation of chronic fibrosing interstitial lung disease with progressive phenotype and potential comorbidities.
June 22, 2020 –
Kelli Davis, METAvivor Patient Advocate and Co-Founder of the Northwest Arkansas Metsquerade, provides an insight into her journey as a patient with metastatic breast cancer and as a patient advocate.
June 22, 2020 –
Considerations for symptoms that are tied to chronic fibrosing interstitial lung disease with progressive phenotype.
June 17, 2020 –
Experts review chronic fibrosing interstitial lung disease with progressive phenotype and its different forms of manifestation.
